ACG Wealth’s Silicon Laboratories SLAB Stock Holding History

ACG Wealth’s Portfolio SLAB Stock Details SLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-100	Closed	-$14K	–	879
2022 Q2	$14K	Buy	+100	New	+$14K	﹤0.01%	646

Other funds holding SLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

PFO

Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

ACG Wealth's SLAB Position: Q3 2022 in Review

ACG Wealth sold out of Silicon Laboratories (SLAB) in Q3 2022, closing a stake of 100 shares — an estimated $14K sold.

ACG Wealth first reported a position in SLAB in Q2 2022 and held it in 1 quarter. The position peaked at $14K in Q2 2022. 305 funds tracked by Wall St. Rank hold SLAB as of Q3 2022.

ACG Wealth reported no remaining Silicon Laboratories position as of Q3 2022 after selling out during the quarter.
ACG Wealth sold 100 Silicon Laboratories shares in Q3 2022, an estimated $14K.
ACG Wealth first reported a position in Silicon Laboratories in Q2 2022 and held it in 1 quarter.
ACG Wealth's Silicon Laboratories position peaked at $14K in Q2 2022.
305 funds tracked by Wall St. Rank held Silicon Laboratories as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.